Arcosa (ACA) Stock Price, News & Analysis

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ACA shares.
View ACA analyst ratings or view top-rated stocks.

5 equities research analysts have issued 1-year target prices for Arcosa's shares. Their ACA share price targets range from $87.00 to $95.00. On average, they expect the company's share price to reach $90.00 in the next twelve months. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for ACA or view top-rated stocks among Wall Street analysts.

Arcosa's stock was trading at $82.64 on January 1st, 2024. Since then, ACA stock has decreased by 8.2% and is now trading at $75.88.
View the best growth stocks for 2024 here.

Arcosa saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 485,700 shares, a decrease of 14.8% from the March 15th total of 569,900 shares. Based on an average daily volume of 212,000 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.0% of the shares of the stock are sold short.
View Arcosa's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ACA earnings forecast.

Arcosa will be holding an earnings conference call on Friday, May 3rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-220-6929.

Arcosa, Inc. (NYSE:ACA) posted its quarterly earnings data on Friday, February, 23rd. The company reported $0.68 earnings per share for the quarter, topping the consensus estimate of $0.33 by $0.35. The firm had revenue of $582.20 million for the quarter, compared to analysts' expectations of $554.54 million. Arcosa had a trailing twelve-month return on equity of 6.90% and a net margin of 6.90%. The company's revenue was up 16.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.24 earnings per share.

Arcosa declared a quarterly dividend on Thursday, March 7th. Shareholders of record on Monday, April 15th will be paid a dividend of $0.05 per share on Tuesday, April 30th. This represents a $0.20 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Friday, April 12th.
Read our dividend analysis for ACA.

Arcosa (NYSE:ACA) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.26%. The dividend payout ratio is 6.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ACA will have a dividend payout ratio of 5.12% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ACA.

ETFs with the largest weight of Arcosa (NYSE:ACA) stock in their portfolio include ProShares S&P Kensho Cleantech ETF (CTEX), First Trust RBA American Industrial Renaissance ETF (AIRR), SPDR S&P Kensho Clean Power ETF (CNRG), First Trust Global Wind Energy ETF (FAN), Invesco S&P SmallCap Industrials ETF (PSCI), Opus Small Cap Value Plus ETF (OSCV), Nuveen Small Cap Select ETF (NSCS) and Invesco S&P SmallCap Quality ETF (XSHQ).

Arcosa issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.5 billion-$2.7 billion, compared to the consensus revenue estimate of $2.5 billion.

15 employees have rated Arcosa Chief Executive Officer Antonio Carrillo on Glassdoor.com. Antonio Carrillo has an approval rating of 91% among the company's employees. This puts Antonio Carrillo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include DexCom (DXCM), AbbVie (ABBV), Walt Disney (DIS), Advanced Micro Devices (AMD), NVIDIA (NVDA), Splunk (SPLK), AT&T (T), Xilinx (XLNX), Activision Blizzard (ATVI) and Alibaba Group (BABA).

Arcosa's stock is owned by a number of institutional and retail investors. Top institutional investors include Synergy Asset Management LLC (0.13%), Hodges Capital Management Inc. (0.12%), State of Alaska Department of Revenue (0.06%), Atlantic Union Bankshares Corp (0.02%), AdvisorNet Financial Inc (0.02%) and Guidance Capital Inc. (0.01%). Insiders that own company stock include Antonio Carrillo, Bryan Stevenson, Gail M Peck, Jesse E Jr Collins, Kerry S Cole, Mary E Henderson and Ronald J Gafford.
View institutional ownership trends.

Shares of ACA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.